India’s Pharmaceutical Industry 3rd Largest Globally by Volume, 11th by Value

Global Pharma Leader: India's 3rd Spot in Volume, 11th in Value - Report Wire

The rise of India’s pharmaceutical industry marks a pivotal chapter in global healthcare. Third in volume and 11th in value worldwide, it boasts 3,000+ companies and over 10,500 production units, forming a robust ecosystem. Domestic sales hit $60 billion, eyeing $130 billion by 2030 amid 7 percent yearly export gains. FY 2024-25 saw turnover at Rs 4.72 lakh crore per Economic Survey 2025-26, reflecting decade-long momentum. Dominating generics w…

India’s Pharma Sector Scales Up, Eyes Bigger Role in Global Healthcare

India’s pharmaceutical industry is no longer just the world’s low-cost supplier of generic medicines. It is steadily building scale, widening its global presence and moving into more complex segments, supported by policy momentum and growing investor confidence. The numbers underline that shift. Pharmaceutical exports reached US$ 30.5 billion in 2024–25, nearly 16 times higher than US$ 1.9 billion in 2000–01. The domestic market, currently value…

India’s pharmaceutical industry 3rd largest globally by volume, 11th by value

New Delhi, March 21, 2026 India’s pharmaceutical industry has evolved into a globally integrated and policy-supported system, ranking third globally by volume and 11th by value, with more than 3,000 companies and 10,500 manufacturing units, an official factsheet showed on Saturday. The domestic pharmaceutical market, valued at $60 billion, is projected to reach $130 billion by 2030. According to the Economic Survey 2025-26, in FY25, the sector’s…